Internal Medicine Doctors in Duluth, MN Accepting Medicare
219 Internal Medicine doctors found. Showing 1 - 20
 Nizar Najib Saleh, Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 |
Dr. Joseph J Martinelli, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 920 E 1st St, Ste P201, Duluth, MN 55805 Phone: 218-249-7970 |
 Gina Marie Slipka-marinos, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 |
Dr. Abdurrahman M Hamadah, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1001 E Superior St Ste L201, Duluth, MN 55802 Phone: 218-249-5555 |
Sarah Jane Nelson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 |
Robert Dale Niedringhaus, Internal Medicine - Hematology Medicare: Not Enrolled in Medicare Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 |
Thomas Edward Russ, Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 |
Luiz Fernando Leonavicius Guimaraes Franco, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 502 E 2nd St, Duluth, MN 55805 Phone: 218-786-8364 |
Dr. Gregory Robert Stroh, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 |
Dr. Shreyas Sushil Shirodkar, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 420 E 1st St, Duluth, MN 55805 Phone: 218-786-8364 Fax: 304-598-4871 |
Dr. George C Apostolou, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 324 W Superior St, Ste. 220, Duluth, MN 55802 Phone: 218-249-3500 Fax: 218-249-3555 |
Dr. Judith Goodrich Arvold, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1001 E Superior St, Suite L401, Duluth, MN 55802 Phone: 218-249-7960 |
George Leighton Satterfield, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 915 E 1st St, Duluth, MN 55805 Phone: 218-249-5555 |
Dr. Jake Richard Powell, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 E Superior St, Suite L401, Duluth, MN 55802 Phone: 218-249-7960 Fax: 218-249-7997 |
Dr. Gratia Lynn Pitcher, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Essentia Health Duluth Clinic, Duluth, MN 55805 Phone: 218-786-8364 |
Yan Dong, MD Internal Medicine - Clinical Cardiac Electrophysiology Medicare: Accepting Medicare Assignments Practice Location: 1001 E Superior St Ste 201, Duluth, MN 55802 Phone: 218-249-3057 |
Dr. Robert Cole Pueringer, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 |
Peter Aas, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 |
John J Degelau, MD Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 407 E 3rd St, Duluth, MN 55805 Phone: 218-786-4000 |
Gale Gordon Kerns, Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 |
News Archive
Sunesis Pharmaceuticals enrolls 113 patients in voreloxin REVEAL-1 trial
Sunesis Pharmaceuticals, Inc. today reported that it has completed enrollment in the REVEAL-1 (Response Evaluation of VorEloxin in AmL) trial, a Phase 2 dose regimen optimization trial of single agent voreloxin in newly diagnosed elderly acute myeloid leukemia (AML) patients who are unlikely to benefit from standard induction chemotherapy. A total of 113 patients were enrolled and dosed according to one of three dosing schedules.
Astellas Pharma acquires OSI Pharmaceuticals for $4.0 billion
Astellas Pharma Inc. announced today that the company has completed its acquisition of OSI Pharmaceuticals, Inc. for $4.0 billion.
Increasing unsustainable prices for leukemia drugs represent larger issue across all cancers
The increasing cost of treatments for chronic myeloid leukemia (CML) in the United States has reached unsustainably high levels and may be leaving many patients under- or untreated because they cannot afford care, according to a Blood Forum article supported by nearly 120 CML experts from more than 15 countries on five continents and published online today in Blood, the Journal of the American Society of Hematology (ASH).
FDA approves Biologics' IMBRUVICA as oral agent for treatment of patients with CLL
Biologics, a limited distribution network partner for IMBRUVICA™ (ibrutinib), is pleased to announce the U.S. Food and Drug Administration (FDA) has approved IMBRUVICA™ (ibrutinib) capsules as a single, oral agent for the treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.
Treatments for anxiety disorders likely to prove efficacious in ASD
A new study in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging reports that anxiety occurring in autism spectrum disorder (ASD) shares similar brain mechanisms as anxiety alone.
› Verified 2 days ago
Internal Medicine
Family Medicine
Emergency Medicine
Pediatrics
Anesthesiology
Psychiatry & Neurology
Surgery
Radiology
Orthopaedic Surgery
Obstetrics & Gynecology